Open Access Open Access  Restricted Access Subscription Access

Determination of Genotoxic melamine impurity in Allopurinol by High performance liquid chromatography

Dr. Amit Gosar, Tabrez Shaikh

Abstract


A rapid, sensitive and highly selective High performance liquid chromatography (HPLC) method was developed and validated for the determination of trace level Genotoxic Melamine impurity, as required by USFDA and that may be present in Allopurinol. HPLC column used was Cosmosil C18 (250 x 4.6 mm, 5µm). The isocratic elution modewas selected where the mobile phaseconsists of 1.25 g/l Sodium dihydrogen phosphate solution. The flow rate was set to1.0 mL/minand run time of 30 minutes. UV detector with wavelength 208 nm was used for theanalysis. The column oven temperature was kept at 25°C. The developed method was validated according to ICH guideline and found to be linear in the range of 5.20 ppm to 52.05 ppm with a correlation coefficient 0.9997. Limit of detection and limit of quantitation was found to be 1.21 ppm and 3.68 ppm respectively. Recovery for this impurity was found between 93.37% and 107.59%.A method was found to be specific, selective, precise, and robust. The developed method can successfully be applied for the determination of Genotoxic Melamine impurity in Allopurinol.


Full Text:

PDF

References


Benezra S.A. & Bennett T. R. Allopurinol. In Analytical profiles of drug substances. Academic Press. 1978.

Al-Salabi M. I. & de Koning H. P. Purine nucleobase transport in amastigotes of Leishmaniamexicana: involvement in allopurinol uptake. Antimicrobial agents and chemotherapy. 2005; 49(9): pp. 3682-3689.

Blaker P.A., Arenas-Hernandez M., Smith M.A., Shobowale-Bakre E.A., Fairbanks L., Irving P.M., Sanderson J.D. & Marinaki A.M. Mechanism of allopurinol induced TPMT inhibition. Biochemical pharmacology. 2013; 86(4): pp. 539-547.

Wood A.J. Playing “kick the FDA”—risk-free to players but hazardous to public health. New England Journal of Medicine. 2008; 358(17): pp. 1774-1775.

Bhalla V., Grimm P.C., Chertow G.M. & Pao A.C. Melamine nephrotoxicity: an emerging epidemic in an era of globalization. Kidney international. 2009; 75(8): pp. 774-779.

Cantor S.L., Gupta A. & Khan M.A. Analytical Methods for the Evaluation of Melamine Contamination. Journal of pharmaceutical sciences. 2014; 103(2): pp. 539-544.

Miao H., Fan S., Zhou P.P., Zhang L., Zhao Y.F. & Wu Y.N. Determination of melamine and its analogues in egg by gas chromatography-tandem mass spectrometry using an isotope dilution technique. Food Additives and Contaminants. 2010; 27(11): pp. 1497-1506.

Smoker M. & Krynitsky A.J. Interim method for determination of melamine and cyanuric acid residues in foods using LC-MS/MS: version 1.0. US FDA Laboratory Information Bulletin. 2008; pp. 4422.

Swartz, Michael E., & Ira S. Krull. Handbook of analytical validation. CRC Press. 2012.

Chan, Chung Chow, et al. eds. Analytical method validation and instrument performance verification. John Wiley & Sons. 2004.

Ermer, Joachim, & John H. McB Miller, eds. John Wiley & Sons. 2006.

Guideline, ICH Harmonised Tripartite. Q2 (R1). International Conference on Harmonization, Geneva, Switzerland. 2005.


Refbacks

  • There are currently no refbacks.